In addition, miR-375 suppresses malignant phenotypes of HCC by targeting Astrocyte elevated gene-1 (AEG-1) and Yes-associated protein 1 (YAP1) which mediate steatosis and hepatic proliferation/differentiation respectively [57,58]. This evidence concerns the gene MTDH and hepatocellular carcinoma.